Ad
MCRB Quote Trading Chart Seres Therapeutics Inc.
home / stock / mcrb / mcrb quote
Quote | Seres Therapeutics Inc. (NASDAQ:MCRB)
| Last: | $0.8485 |
|---|---|
| Change Percent: | -1.53% |
| Open: | $0.85 |
| Close: | $0.8485 |
| High: | $0.8646 |
| Low: | $0.83 |
| Volume: | 2,118,523 |
| Last Trade Date Time: | 10/04/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
MCRB Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $0.8485 | $0.85 | $0.8485 | $0.8646 | $0.83 | 2,118,523 | 10-04-2024 |
| $0.8372 | $0.8501 | $0.8372 | $0.8998 | $0.8372 | 3,339,048 | 10-03-2024 |
| $0.9023 | $0.9307 | $0.9023 | $0.9499 | $0.8709 | 2,604,886 | 10-02-2024 |
| $0.9613 | $0.82 | $0.9613 | $0.966 | $0.8 | 9,474,110 | 10-01-2024 |
| $0.9461 | $0.97 | $0.9461 | $1.07 | $0.9412 | 7,004,605 | 09-30-2024 |
| $0.9189 | $0.87 | $0.9189 | $1.01 | $0.84 | 12,048,641 | 09-27-2024 |
| $0.832 | $0.98 | $0.832 | $0.98 | $0.79801 | 10,742,589 | 09-26-2024 |
| $0.9153 | $1.09 | $0.9153 | $1.1 | $0.9063 | 12,058,172 | 09-25-2024 |
| $1.11 | $1.14 | $1.11 | $1.16 | $1.1 | 3,818,255 | 09-24-2024 |
| $1.16 | $1.13 | $1.16 | $1.21 | $1.095 | 5,193,938 | 09-23-2024 |
| $1.13 | $1.02 | $1.13 | $1.13 | $0.9959 | 6,410,798 | 09-20-2024 |
| $1.05 | $1.09 | $1.05 | $1.1 | $1.02 | 2,508,166 | 09-19-2024 |
| $1.05 | $1.1 | $1.05 | $1.13 | $1.04 | 2,889,608 | 09-18-2024 |
| $1.1 | $1.03 | $1.1 | $1.14 | $1.02 | 4,355,479 | 09-17-2024 |
| $1.02 | $0.99 | $1.02 | $1.07 | $0.9815 | 2,599,733 | 09-16-2024 |
| $0.9992 | $0.94 | $0.9992 | $1 | $0.9104 | 3,087,277 | 09-13-2024 |
| $0.96 | $1.1 | $0.96 | $1.2 | $0.92 | 8,116,377 | 09-12-2024 |
| $1.05 | $1.03 | $1.05 | $1.075 | $1 | 1,850,057 | 09-11-2024 |
| $1.03 | $1.03 | $1.03 | $1.065 | $0.9655 | 3,290,751 | 09-10-2024 |
| $1.03 | $0.96 | $1.03 | $1.11 | $0.9108 | 5,794,700 | 09-09-2024 |
News, Short Squeeze, Breakout and More Instantly...
Seres Therapeutics Inc. Company Name:
MCRB Stock Symbol:
NASDAQ Market:
Seres Therapeutics Inc. Website:
Ad
-
Transaction supports further development of SER-155, following recent promising clinical data, and other cultivated live biotherapeutics, for multiple medically vulnerable patient populations at high risk of life-threatening bacterial infections Cash received at completion, along with a...
-
CAMBRIDGE, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (“Seres” or the “Company”), a leading live biotherapeutics company, today announced that its stockholders voted to approve the previously announced proposed sale of the C...
-
CAMBRIDGE, Mass., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that the Company, will participate in the Cantor Global Healthcare Conference and Eric Shaff, President and Chief Executive Officer, will represent...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...